This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-growth: Archive
Is It Worth Investing in Coupang (CPNG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Coupang (CPNG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CPNGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Booking Holdings (BKNG) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Booking Holdings (BKNG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BKNGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Shopify (SHOP): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Shopify (SHOP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SHOPPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CLSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is SYMBOTIC INC (SYM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), SYMBOTIC INC (SYM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SYMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Here is Why Growth Investors Should Buy CSW Industrials (CSWI) Now
by Zacks Equity Research
CSW Industrials (CSWI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CSWIPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Skechers (SKX) Now
by Zacks Equity Research
Skechers (SKX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
SKXPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
SEI (SEIC) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
SEI (SEIC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
SEICPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why Blachem (BCPC) is a Solid Choice
by Zacks Equity Research
Blachem (BCPC) could produce exceptional returns because of its solid growth attributes.
BCPCPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Leidos (LDOS) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Leidos (LDOS) possesses solid growth attributes, which could help it handily outperform the market.
LDOSNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why Silicon Motion (SIMO) is a Solid Choice
by Zacks Equity Research
Silicon Motion (SIMO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
SIMOPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Universal Health Services (UHS) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Universal Health Services (UHS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
UHSPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Brokers Suggest Investing in Leidos (LDOS): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Leidos (LDOS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LDOSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on Pilgrim's Pride (PPC): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Pilgrim's Pride (PPC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PPCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Nextracker (NXT) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Nextracker (NXT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NXTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Gray Television (GTN) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Gray Television (GTN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
GTNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Duke Energy (DUK): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Duke Energy (DUK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DUKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Berkshire Hathaway B (BRK.B) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Berkshire Hathaway B (BRK.B) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BRK.BPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Synopsys (SNPS): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SNPSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in MoneyLion (ML): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), MoneyLion (ML) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Silicon Motion (SIMO) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Silicon Motion (SIMO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SIMOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ABTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Why Growth Investors Shouldn't Overlook Walmart (WMT)
by Zacks Equity Research
Walmart (WMT) possesses solid growth attributes, which could help it handily outperform the market.
WMTNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Baker Hughes (BKR) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Baker Hughes (BKR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
BKRPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks